This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Makris M, Konkle BA. Hepatitis C in haemophilia: time for treatment for all. Haemophilia 2017; 23(2): 180-1. doi:10.1111/ hae.13183.MakrisMKonkleBAHepatitis C in haemophilia: time for treatment for allHaemophilia2017232180110.1111/hae.1318328300362Open DOISearch in Google Scholar
Evatt BL. The tragic history of AIDS in the hemophilia population. 1982-1984. J Thromb Haemost 2006; 4(11): 2295301. doi 10.1111/j.1538-7836.2006.02213.x.EvattBLThe tragic history of AIDS in the hemophilia population. 1982-1984J Thromb Haemost2006411229530110.1111/j.1538-7836.2006.02213.x16972935Open DOISearch in Google Scholar
O’Mahony B, Noone D, Giangrande PLF, Prihodova L. Haemophilia care in Europe – a survey of 35 countries. Haemophilia 2013; 19(4): e239-47. doi:10.1111/hae.12125.O’MahonyBNooneDGiangrandePLFPrihodovaLHaemophilia care in Europe – a survey of 35 countriesHaemophilia2013194e2394710.1111/hae.1212523557438Open DOISearch in Google Scholar
World Federation of Hemophilia. Report on the Annual Global Survey 2014 2015. Available from http://www1.wfh.org/publications/files/pdf-1627.pdf (accessed 13 March 2018).World Federation of HemophiliaReport on the Annual Global Survey 20142015Available fromhttp://www1.wfh.org/publications/files/pdf-1627.pdfaccessed 13 March 2018Search in Google Scholar
Lee YA, Friedman SL. Reversal, maintenance or progression: what happens to the liver after a virologic cure of hepatitis C? Antiviral Res 2014; 107: 23-30. doi:10.1016/j. antiviral.2014.03.012.LeeYAFriedmanSLReversal, maintenance or progression: what happens to the liver after a virologic cure of hepatitis C?Antiviral Res2014107233010.1016/j.antiviral.2014.03.012405074424726738Open DOISearch in Google Scholar
Persico M, Rosato V, Aglitti A, et al. Sustained virological response by direct antiviral agents in HCV leads to an early and significant improvement of liver fibrosis. Antivir Ther 2017. doi:10.3851/IMP3186. [Epub ahead of print].PersicoMRosatoVAglittiAet alSustained virological response by direct antiviral agents in HCV leads to an early and significant improvement of liver fibrosisAntivir Ther201710.3851/IMP3186Epub ahead of print28799522Open DOISearch in Google Scholar
El Sherif O, Afhdal N, Curry M. No one size fits all-Shortening duration of therapy with direct-acting antivirals for hepatitis C genotype 1 infection. J Viral Hepat 2017; 24(10): 808-13. doi:10.1111/jvh.12734.El SherifOAfhdalNCurryMNo one size fits all-Shortening duration of therapy with direct-acting antivirals for hepatitis C genotype 1 infectionJ Viral Hepat201724108081310.1111/jvh.1273428581634Open DOISearch in Google Scholar
Posthouwer D, Plug I, van der Bom JG, et al. Hepatitis C and health-related quality of life among patients with hemophilia. Haematologica 2005; 90(6): 846-50.PosthouwerDPlugIvan derBom JGet alHepatitis C and health-related quality of life among patients with hemophiliaHaematologica200590684650Search in Google Scholar
Health Protection Surveillance Centre, Ireland. National Hepatitis C Database for infection acquired through blood and blood products: 2015 Report. [2015] Available from https://www.hpsc.ie/a-z/hepatitis/hepatitisc/hepatitiscdatabase/baselineandfollow-upreports/File,15238,en.pdf (accessed 13 March 2018).Health Protection Surveillance Centre, IrelandNational Hepatitis C Database for infection acquired through blood and blood products2015Report. [2015]. Available fromhttps://www.hpsc.ie/a-z/hepatitis/hepatitisc/hepatitiscdatabase/baselineandfollow-upreports/File,15238,en.pdfaccessed 13 March 2018Search in Google Scholar
Lövdahl S, Henriksson KM, Baghaei F, et al. Incidence, mortality rates and causes of deaths in haemophilia patients in Sweden. Haemophilia 2013;19(3): 362-9. doi:10.1111/hae.12092.LövdahlSHenrikssonKMBaghaeiFet alIncidence, mortality rates and causes of deaths in haemophilia patients in SwedenHaemophilia2013193362910.1111/hae.1209223374117Open DOISearch in Google Scholar
Posthouwer D, Plug I, van der Bom JG, et al. Hepatitis C infection among Dutch haemophilia patients: a nationwide cross-sectional study of prevalence and antiviral treatment. Haemophilia 2005; 11(3): 270-5. doi:10.1111/j.1365-2516.2005.01083.x.PosthouwerDPlugIvan derBom JGet alHepatitis C infection among Dutch haemophilia patients: a nationwide cross-sectional study of prevalence and antiviral treatmentHaemophilia2005113270510.1111/j.1365-2516.2005.01083.x15876273Open DOISearch in Google Scholar
Ebeling F, Rasi V, Laitinen H, Krusius T. Viral markers and use of factor products among Finnish patients with bleeding disorders. Haemophilia 2001; 7(1): 42-6.EbelingFRasiVLaitinenHKrusiusTViral markers and use of factor products among Finnish patients with bleeding disordersHaemophilia20017142610.1111/j.1365-2516.2001.00477.xSearch in Google Scholar
Irish Haemophilia Society celebrates eradication of Hepatitis C among members. Irish Examiner 22 December 2016. Available from https://www.irishexaminer.com/breakingnews/ireland/irish-haemophilia-society-celebrates-eradication-of-hepatitis-c-among-members-769660.html (accessed 13 March 2018).Irish Haemophilia Society celebrates eradication of Hepatitis C among membersIrish Examiner22 December2016Available fromhttps://www.irishexaminer.com/breakingnews/ireland/irish-haemophilia-society-celebrates-eradication-of-hepatitis-c-among-members-769660.htmlaccessed 13 March 2018Search in Google Scholar
Cortez-Pinto H. National HCV programmes: a European approach to eliminating hepatitis C. Presentation delivered at the European Haemophilia Consortium Round Table of Stakeholders: HCV and Haemophilia, Brussels, June 2016. Available from https://static.ehc.eu/wp-content/uploads/09-EHC-June-RT-Presentation-Cortez-Pinto-FOR-DISTRIBUTION.pdf (accessed 14 May 2018).Cortez-PintoH.National HCV programmes: a European approach to eliminating hepatitis C. Presentation delivered at the European Haemophilia Consortium Round Table of StakeholdersHCV and HaemophiliaBrusselsJune2016Available fromhttps://static.ehc.eu/wp-content/uploads/09-EHC-June-RT-Presentation-Cortez-Pinto-FOR-DISTRIBUTION.pdfaccessed 14 May 2018Search in Google Scholar
Graham K. Portugal agrees to treat 13,000 Hepatitis C sufferers for free. Digital Journal 8 Feb 2015. Available from http://www.digitaljournal.com/life/health/portugal-agrees-to-treat-13-000-hepatitis-c-sufferers-for-free/article/425590 (accessed 13 March 2018).GrahamKPortugal agrees to treat 13,000 Hepatitis C sufferers for freeDigital Journal8 Feb2015Available fromhttp://www.digitaljournal.com/life/health/portugal-agrees-to-treat-13-000-hepatitis-c-sufferers-for-free/article/425590accessed 13 March 2018Search in Google Scholar
Giangrande PLF, Peyvandi F, O’Mahony B, et al. Kreuth IV: European consensus proposals for treatment of haemophilia with coagulation factor concentrates. Haemophilia 2017; 23(3): 370-5. doi:10.1111/hae.13211.GiangrandePLFPeyvandiFO’MahonyBet alKreuth IV: European consensus proposals for treatment of haemophilia with coagulation factor concentratesHaemophilia2017233370510.1111/hae.1321128401658Open DOISearch in Google Scholar
Kattakuzhy S, Gross C, Emmanuel B, et al. Expansion of treatment for hepatitis C virus infection by task shifting to community-based nonspecialist providers. Ann Intern Med 2017; 167(5): 311-8. doi:10.7326/M17-0118.KattakuzhySGrossCEmmanuelBet alExpansion of treatment for hepatitis C virus infection by task shifting to community-based nonspecialist providersAnn Intern Med20171675311810.7326/M17-0118573638128785771Open DOISearch in Google Scholar
Nyalakonda H, Utay NS. A new era of therapy for hepatitis C virus infection. Curr Opin Infect Di. 2015; 28(5): 471-8. doi:10.1097/QCO.0000000000000190.NyalakondaHUtayNSA new era of therapy for hepatitis C virus infectionCurr Opin Infect Di2015285471810.1097/QCO.000000000000019026203851Open DOISearch in Google Scholar
Cousins S. The Tasmanian Hep C Buyers’ Club. New York Times 25 July 2017. Available from https://www.nytimes.com/2017/07/25/opinion/the-tasmanian-hep-c-buyers-club.html (accessed 13 March 2018).CousinsSThe Tasmanian Hep C Buyers’ ClubNew York Times25 July2017Available fromhttps://www.nytimes.com/2017/07/25/opinion/the-tasmanian-hep-c-buyers-club.htmlaccessed 13 March 2018Search in Google Scholar
